TNFRSF11A and head and neck squamous cell carcinoma: To confirm the autocrine/paracrine function of RANKL in HNSCC, we utilized the soluble RANKL decoy receptor osteoprotegerin (OPG), which inhibits the RANKL-RANK pathway by sequestering RANKL30, 31, 32, 33.